BAB-104

N/A

Report date: 2023/11/03 17:02:21

Base Information

Drug NameBAB-104
Drug Alias NameBAB-104
ClassificationBiologics
Mechanisms of ActionTranscriptional enhancer factor inhibitors
TargetsTranscriptional enhancer factor
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMeningiomaMesothelioma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaobab Aibio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBaobab Aibio Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungMeningiomaMesothelioma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A